Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Dec 8.
doi: 10.1111/jgh.70177. Online ahead of print.

Chronic Hepatitis B Infection: Patient Guidance

Lung-Yi Mak  1 , Jimmy Che-To Lai  2 , Ken Liu  3 , Rashid Lui  2 , Sakkarin Chirapongsathorn  4 , Kuo Chao Yew  5 , Mara Teresa Panlilio  6 , Cosmas Rinaldi Adithya Lesmana  7 , Ruveena Bhavani Rajaram  8 , Liang Shen  9 , Desmond Cheung  10 , Lung-Fai Wong  10 , Hye Won Lee  11 , Madhumita Premkumar  12 , Anand V Kulkarni  13 , Nobuharu Tamaki  14 , Yao Chun Hsu  15   16 , Daniel Q Huang  17
Affiliations
Review

Chronic Hepatitis B Infection: Patient Guidance

Lung-Yi Mak et al. J Gastroenterol Hepatol. .

Abstract

This patient guidance document is intended for all people at risk of or living with chronic hepatitis B (CHB) infection. Globally, CHB is one of the leading causes of cirrhosis and hepatocellular carcinoma, the most common form of liver cancer. However, less than one in five infected individuals is aware of their condition and only a small fraction of these individuals receive proper assessment and management. Safe and effective treatment is available in many countries and regions and is recommended for infected individuals who have evidence of liver damage or are at risk of complications. Several essential measures are advised for all people living with CHB, including lifestyle habits, screening for coinfection, managing comorbidities, fibrosis assessment, preventing HBV transmission, and surveillance for liver cancer. There are also recent shifts in the treatment paradigm and novel drug development. In those living with CHB, a better understanding of the disease can empower them to play an active role in management in partnership with their physicians. This guidance document has been developed in collaboration with clinicians, scientists, patients, and patient representatives to summarize updated salient knowledge to inform people at risk of or living with CHB.

Keywords: chronic infection; health literacy; hepatitis B virus; patient empowerment.

PubMed Disclaimer

References

    1. L. Y. Mak, K. Liu, S. Chirapongsathorn, et al., “Liver Diseases and Hepatocellular Carcinoma in the Asia‐Pacific Region: Burden, Trends, Challenges and Future Directions,” Nature Reviews. Gastroenterology & Hepatology 21 (2024): 834–851.
    1. Polaris Observatory C, “Global Prevalence, Cascade of Care, and Prophylaxis Coverage of Hepatitis B in 2022: A Modelling Study,” Lancet Gastroenterology & Hepatology 8 (2023): 879–907.
    1. E. E. Mast, M. J. Alter, and H. S. Margolis, “Strategies to Prevent and Control Hepatitis B and C Virus Infections: A Global Perspective,” Vaccine 17 (1999): 1730–1733.
    1. W. J. Jeng, G. V. Papatheodoridis, and A. S. F. Lok, “Hepatitis B,” Lancet 401 (2023): 1039–1052.
    1. S. K. Sarin, M. Kumar, G. K. Lau, et al., “Asian‐Pacific Clinical Practice Guidelines on the Management of Hepatitis B: A 2015 Update,” Hepatology International 10 (2016): 1–98.

LinkOut - more resources